Renal Dose Adjustment for Meropenem
For adult patients with renal impairment, calculate creatinine clearance using the Cockcroft-Gault equation and adjust meropenem dosing according to the FDA-approved schedule: reduce to half the recommended dose every 12 hours for CrCl 10-25 mL/min, and half the recommended dose every 24 hours for CrCl <10 mL/min. 1
Step-by-Step Dosing Algorithm
Step 1: Calculate Creatinine Clearance
Use the Cockcroft-Gault equation to estimate creatinine clearance 1:
- Males: CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
- Females: 0.85 × above value
Important caveat: While the Cockcroft-Gault equation is FDA-recommended for meropenem dosing, measured 24-hour urine creatinine clearance is significantly more accurate in critically ill patients, as estimated equations can grossly over- or underestimate renal function 2, 3. If available, use measured creatinine clearance for dose calculations 4.
Step 2: Determine Standard Dose Based on Infection Type
Adult patients 1:
- Complicated skin/skin structure infections: 500 mg every 8 hours
- Complicated skin/skin structure with P. aeruginosa: 1 gram every 8 hours
- Complicated intra-abdominal infections: 1 gram every 8 hours
Step 3: Apply Renal Adjustment
FDA-approved dosing schedule for adults with renal impairment 1:
| Creatinine Clearance | Dose Adjustment | Dosing Interval |
|---|---|---|
| >50 mL/min | Full recommended dose | Every 8 hours |
| 26-50 mL/min | Full recommended dose | Every 12 hours |
| 10-25 mL/min | Half recommended dose | Every 12 hours |
| <10 mL/min | Half recommended dose | Every 24 hours |
Example: For a patient with CrCl 20 mL/min requiring treatment for intra-abdominal infection:
- Standard dose: 1 gram every 8 hours
- Adjusted dose: 500 mg every 12 hours
Step 4: Consider Administration Method
- Standard infusion: 15-30 minutes for all doses 1
- Bolus injection: 3-5 minutes for 1 gram doses only 1
- Extended infusion: 3-4 hour infusions improve target attainment in patients with augmented renal clearance (CrCl >85 mL/min) 3, 5
Critical Considerations for Special Populations
Critically Ill Patients
Augmented renal clearance (CrCl >130 mL/min) is common in septic ICU patients and leads to subtherapeutic meropenem levels 3, 6. For these patients:
- Standard dosing frequently fails to achieve pharmacodynamic targets 6
- Consider 1 gram every 8 hours as 8-hour continuous infusion for CrCl ≥130 mL/min 3
- Therapeutic drug monitoring is highly beneficial when available 2
Pediatric Patients ≥3 Months
Weight-based dosing with renal adjustment 1:
- Calculate dose based on infection type (10-40 mg/kg every 8 hours, maximum 2 grams)
- No established pediatric renal adjustment guidelines exist 1
- Use clinical judgment and consider therapeutic drug monitoring
Hemodialysis Patients
Inadequate data exists for meropenem dosing in hemodialysis or peritoneal dialysis 1. The FDA label provides no specific recommendations for these populations, necessitating individualized approaches with infectious disease consultation.
Common Pitfalls to Avoid
Using estimated GFR equations in critically ill patients: Creatinine-based equations (MDRD, CKD-EPI) significantly overestimate renal function across most GFR ranges in ICU patients, leading to underdosing 2, 7. Measured creatinine clearance is superior 2.
Failing to recognize augmented renal clearance: Up to 40% of septic ICU patients have CrCl >130 mL/min, requiring higher doses or extended infusions to achieve therapeutic targets 3, 6.
Not reassessing renal function: Renal function changes rapidly in critically ill patients 4. Recalculate creatinine clearance whenever clinical status changes significantly 4.
Ignoring MIC values: Standard dosing achieves adequate exposure for MIC ≤2 mg/L but frequently fails for MIC 8 mg/L, particularly in patients with normal or augmented renal function 6.